𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder

✍ Scribed by Stuart Fine; Charlotte Johnston

Publisher
Springer US
Year
1993
Tongue
English
Weight
297 KB
Volume
24
Category
Article
ISSN
0009-398X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of reboxetine in adults with at
Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial
✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

Amantadine versus methylphenidate in chi
Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial
✍ Mohammad-Reza Mohammadi; Mohammad-Reza Kazemi; Ebtehal Zia; Shams-Ali Rezazadeh; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Objective The aim of the present study was to further evaluate, under double blind and controlled conditions, the efficacy of amantadine for attention‐deficit/hyperactivity disorder (ADHD) in children and adolescents as compared to methylphenidate. Methods This was a 6‐week randomized